Bay Street News, February, 2024

Preparing Pre-Investigational New Drug Application for lead drug program SPC-15 Company plans to pursue FDA streamlined 505(b)(2) pathway for clinical […]

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) […]

HUNTSVILLE, Ala., Feb. 01, 2024 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) delivered the first production Integrated Battle Command […]

Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp […]

NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Verizon customers will have one of the hottest tickets in Las Vegas […]

MONTRÉAL, 01 févr. 2024 (GLOBE NEWSWIRE) — Ressources Cerro de Pasco Inc. (CSE:CDPR) (OTCPK : GPPRF) (FRA : N8HP) (« CDPR » ou […]

SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]

MONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE:CDPR) (OTCPK: GPPRF) (FRA: N8HP) (“CDPR” or the […]

COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio […]

PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), a pioneer in […]